A Phase I Multiple Ascending Dose Study of BMS-754807 in Combination With Paclitaxel and Carboplatin in Subjects With Advanced or Metastatic Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 12 Jul 2012
At a glance
- Drugs BMS 754807; Carboplatin; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- 12 Jul 2012 Actual patient numbers amended from 56 to 21 as reported by ClinicalTrials.gov.
- 12 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 12 Jul 2012 Actual initiation date changed from Dec 2007 to Apr 2009 as reported by ClinicalTrials.gov.